Best of November: Top 5 Insights In Clinical Supply Chain & Logistics

#1 - Sourcing Plasmid DNA From CDMOs Got More Challenging — Here's Why

The demand for plasmid DNA products is intrinsically linked to unique market conditions and funding environments. Here's what's driving them.

#2 - Why You Should Expect More from Your IRT/RTSM

Explore the need for advanced capabilities beyond basic RTSM and the importance of having experienced teams behind IRT solutions to ensure successful trial execution.

#3 - Cell & Gene Therapies: Avoid This Common Pitfall In Supply Chain Planning

BioPhorum members propose a Design for Supply model for cell and gene therapy supply chain planning. Don't let it take a backseat until the later stages of the product life cycle.

#4 - The Tale Of Two Clinical Supply Chains: The Risks Of Fragmented Systems

This article examines two contrasting approaches to showcase how a centralized inventory management system is an effective tool for supporting a robust supply chain.

#5 - 3 Focus Areas To Transition From Clinical To Commercial Readiness

Transitioning from clinical-stage operations to commercial readiness is a multifaceted process. Establish compliant and robust distribution systems by focusing on these three areas.